-
1
-
-
0036781811
-
Ligand-targeted therapeutics in anticancer therapy
-
Allen TM. Ligand-targeted therapeutics in anticancer therapy. Nat Rev Cancer 2002;2:750-63.
-
(2002)
Nat Rev Cancer
, vol.2
, pp. 750-763
-
-
Allen, T.M.1
-
2
-
-
27144449009
-
Monoclonal antibody therapy of cancer
-
Adams GP, Weiner LM. Monoclonal antibody therapy of cancer. Nat Biotechnol 2005;23:1147-57.
-
(2005)
Nat Biotechnol
, vol.23
, pp. 1147-1157
-
-
Adams, G.P.1
Weiner, L.M.2
-
3
-
-
27144432842
-
Engineered antibody fragments and the rise of single domains
-
Holliger P, Hudson PJ. Engineered antibody fragments and the rise of single domains. Nat Biotechnol 2005;23:1126-36.
-
(2005)
Nat Biotechnol
, vol.23
, pp. 1126-1136
-
-
Holliger, P.1
Hudson, P.J.2
-
5
-
-
0042787657
-
Progress in immunoconjugate cancer therapeutics
-
Payne G. Progress in immunoconjugate cancer therapeutics. Cancer Cell 2003;3:207-12.
-
(2003)
Cancer Cell
, vol.3
, pp. 207-212
-
-
Payne, G.1
-
7
-
-
27144550160
-
Arming antibodies: Prospects and challenges for immunoconjugates
-
Wu AM, Senter PD. Arming antibodies: Prospects and challenges for immunoconjugates. Nat Biotechnol 2005;23:1137-46.
-
(2005)
Nat Biotechnol
, vol.23
, pp. 1137-1146
-
-
Wu, A.M.1
Senter, P.D.2
-
8
-
-
67650678448
-
Humanized immunotoxins: A new generation of immunotoxins for targeted cancer therapy
-
Mathew M, Verma RS. Humanized immunotoxins: A new generation of immunotoxins for targeted cancer therapy. Cancer Sci 2009;100:1359-65.
-
(2009)
Cancer Sci
, vol.100
, pp. 1359-1365
-
-
Mathew, M.1
Verma, R.S.2
-
9
-
-
38549175830
-
DNA vaccines: Precision tools for activating eff ective immunity against cancer
-
Rice J, Ott ensmeier CH, Stevenson FK. DNA vaccines: Precision tools for activating eff ective immunity against cancer. Nat Rev Cancer 2008;8:108-20.
-
(2008)
Nat Rev Cancer
, vol.8
, pp. 108-120
-
-
Rice, J.1
Ottensmeier, C.H.2
Stevenson, F.K.3
-
10
-
-
0032738026
-
Advances in vaccine adjuvants
-
Singh M, O'Hagan D. Advances in vaccine adjuvants. Nat Biotechnol 1999;17:1075-81.
-
(1999)
Nat Biotechnol
, vol.17
, pp. 1075-1081
-
-
Singh, M.1
O'Hagan, D.2
-
11
-
-
0031251876
-
The immunotargeting approach to adjuvant-independent subunit vaccine design
-
Barber BH. The immunotargeting approach to adjuvant-independent subunit vaccine design. Semin Immunol 1997;9:293-301.
-
(1997)
Semin Immunol
, vol.9
, pp. 293-301
-
-
Barber, B.H.1
-
12
-
-
0035902115
-
Proliferation, cell cycle and apoptosis in cancer
-
Evan GI, Vousden KH. Proliferation, cell cycle and apoptosis in cancer. Nature 2001;411:342-8.
-
(2001)
Nature
, vol.411
, pp. 342-348
-
-
Evan, G.I.1
Vousden, K.H.2
-
13
-
-
23844474160
-
Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors
-
Song E, Zhu P, Lee SK, Chowdhury D, Kussman S, Dykxhoorn DM, et al. Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors. Nat Biotechnol 2005;23:709-17.
-
(2005)
Nat Biotechnol
, vol.23
, pp. 709-717
-
-
Song, E.1
Zhu, P.2
Lee, S.K.3
Chowdhury, D.4
Kussman, S.5
Dykxhoorn, D.M.6
-
14
-
-
0035499267
-
Stem cells, cancer, and cancer stem cells
-
Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature 2001;414:105-11.
-
(2001)
Nature
, vol.414
, pp. 105-111
-
-
Reya, T.1
Morrison, S.J.2
Clarke, M.F.3
Weissman, I.L.4
-
15
-
-
9244222261
-
Targeted cancer therapy
-
Sawyers C. Targeted cancer therapy. Nature 2004;432:294-7.
-
(2004)
Nature
, vol.432
, pp. 294-297
-
-
Sawyers, C.1
|